Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_provenance.
- NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_assertion description "[Treatment with oncostatin M (OSM), interleukin (IL)-1 and tumor necrosis factor (TNF)-alpha induced the expression of 18, 22 and 24 kDa bFGF isoforms in KS and human umbilical vein endothelial cells (HUVEC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_provenance.
- NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_assertion evidence source_evidence_literature NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_provenance.
- NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_assertion SIO_000772 9456251 NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_provenance.
- NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_assertion wasDerivedFrom befree-20140225 NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_provenance.
- NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_assertion wasGeneratedBy ECO_0000203 NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_provenance.
- befree-20140225 importedOn "2014-02-25" NP563156.RARsbmcfdsBbTbqdtqZvZa0SmvtXNFJVkoLXGJ_ysrN_g130_provenance.